$Prospective randomized controlled trial comparing treatment efficacy and tolerance of picosecond alexandrite laser with a diffractive lens array and triple combination cream in female asian patients with melasma$

Prospective randomized controlled trial comparing treatment efficacy and tolerance of picosecond alexandrite laser with a diffractive lens array and triple combination cream in female asian patients with melasma

Background Recent evidence suggests melasma to be a photoaging disorder. Triple combination creams (TCC: fluocinolone acetonide 0.01%, hydroquinone 4% and tretinoin 0.05%) remain the gold standard treatment. Picosecond alexandrite laser treatment using a diffractive lens array (DLA) has been identif...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Journal of the European Academy of Dermatology and Venereology 2020-03, Vol.34 (3), p.624-632
Hauptverfasser:	Wang, Y.‐J., Lin, E.‐T., Chen, Y.‐T., Chiu, P.‐C., Lin, B.‐S., Chiang, H.‐M., Huang, Y.‐H., Wang, K.‐Y., Lin, H.‐Y., Chang, T.‐M., Chang, C.‐C.
Format:	Artikel
Sprache:	eng
Schlagworte:	Adult Asian Continental Ancestry Group Combined Modality Therapy Drug Combinations Female Fluocinolone Acetonide - administration & dosage Humans Hydroquinones - administration & dosage Lasers, Solid-State - therapeutic use Melanosis - drug therapy Melanosis - surgery Middle Aged Ointments Prospective Studies Single-Blind Method Treatment Outcome Tretinoin - administration & dosage
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!